Biomerica, Inc. (BMRA)

Nasdaq: BMRA · In Vitro & In Vivo Diagnostic Substances · Irvine, CA · filing with the SEC since 1995

Grade3.7

◀ Past 3.2● Present 3.5▶ Future 4.2

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in May.

Income statement, by fiscal year, newest first
Fiscal year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	May 31, 2026	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021	May 31, 2020	May 31, 2019	May 31, 2018	May 31, 2017
Report filed	Aug 31, 2026	Aug 29, 2025	Aug 28, 2024	Aug 25, 2023	Aug 29, 2022	Aug 27, 2021	Aug 31, 2020	Aug 29, 2019	Aug 29, 2018	Aug 29, 2017
Revenue	4,453,000	5,311,000	5,415,000	5,339,000	18,871,000	7,199,027	6,692,711	5,200,682	5,564,185	5,791,670
For lenders
Interest and dividend income	1,233,000	165,000	431,000	133,000	·	·	·	·	·	·
Interest and investment income	·	·	·	133,000	27,000^r	66,863	71,193	44,014	47,764	46,354
Cost of revenue	4,091,000	4,813,000	4,804,000	4,893,000	15,894,000^r	6,832,742^r	4,954,484^r	3,908,668	3,809,785	3,769,879
Gross profit	362,000	498,000	611,000	446,000	2,977,000^r	366,285^r	1,738,227^r	1,292,014	1,754,400	2,021,791
Research and development	788,000	1,023,000	1,491,000	1,584,000	1,812,000^r	2,194,461^r	1,932,570^r	1,679,098	1,398,368	1,130,635
Selling, general and administrative	4,894,000	4,612,000	5,487,000	6,085,000	5,699,000^r	5,671,517^r	2,546,622^r	2,025,706	1,837,787	1,845,789
Sales and marketing	1,665,000	1,628,000	2,339,000	·	·	·	·	·	·	·
General and administrative	3,229,000	2,984,000	3,148,000	·	·	·	·	·	·	·
Total operating expenses	5,682,000	5,635,000	6,978,000	7,669,000	7,511,000^r	7,865,978^r	4,479,192^r	3,704,804	3,236,155	2,976,424
Operating income	-5,320,000	-5,137,000	-6,367,000	-7,223,000	-4,534,000^r	-7,499,693^r	-2,740,965^r	-2,412,790	-1,481,755	-954,633
Interest expense	·	·	·	·	·	367	9	47	37	282
Total non-operating income (expense)	1,568,000	165,000	431,000	134,000	27,000^r	66,496	71,184	43,967	47,727	46,072
Income before income taxes	-3,752,000	-4,972,000	-5,936,000	-7,089,000	-4,507,000^r	-7,433,197^r	-2,669,781^r	-2,368,823	-1,434,028	-908,561
Income tax expense	23,000	1,000	42,000	51,000	24,000^r	13,057	7,390	24,237	31,800	·
Net income	-3,775,000	-4,973,000	-5,978,000	-7,140,000	-4,531,000^r	-7,446,254^r	-2,677,171^r	-2,393,060	-1,465,828	-908,561
Earnings per share, basic	-1.30	-2.16	-2.84^r	-4.00^b	-2.88^b	-4.96^rb	-2.08^rb	-2.08^b	-1.36^b	-0.88^b
Earnings per share, diluted	-1.30	-2.16	-2.84^r	-4.00^b	-2.88^b	-4.96^rb	-2.08^rb	-2.08^b	-1.36^b	-0.88^b
Weighted average shares, basic	2,914,923	2,297,057	2,103,154^r	1,769,284^b	1,584,156^b	1,491,118^b	1,270,787^b	1,151,570^b	1,071,254^b	1,041,221^b
Weighted average shares, diluted	2,914,923	2,297,057	2,103,154^r	1,769,284^b	1,584,156^b	1,491,118^b	1,270,787^b	1,151,570^b	1,071,254^b	1,041,221^b

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-8 reverse split.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Revenue what customers paid for what it sold

us-gaap:Revenues
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:SalesRevenueNet

Interest and dividend income what its loans and securities earnedus-gaap:InterestAndDividendIncomeOperating

Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterestAndDividend

Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfRevenue

Gross profit revenue less the cost of what it soldus-gaap:GrossProfit

Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense

Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense

Sales and marketing the cost of finding and serving customersus-gaap:SellingAndMarketingExpense

General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense

Total operating expenses the running costs togetherus-gaap:OperatingExpenses

Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss

Interest expense what its borrowing costus-gaap:InterestExpense

Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense

Income before income taxes profit before tax

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments

Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit

Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss

Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic

Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted

Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic

Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

SI Assistanton BMRA · research, not advice